The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The global Ophthalmic Drugs market was valued at US$ 33810 million in 2023 and is anticipated to reach US$ 57200 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Drugs.
Report Scope
The Ophthalmic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Santen Pharmaceutical
- Bausch Health
- Takeda
- Novartis
- Genentech
- Allergan
- Sun Pharmaceutical Industries
- Actavis Generics
- Regeneron Pharmaceuticals
- Pfizer
- Johnson and Johnson
- Bausch and Lomb
Segment by Type
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
Segment by Application
- Hospital
- Clinic
- Pharmacy
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Ophthalmic Drugs Market Overview
1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Ophthalmic Drugs Segment by Type
1.2.1 Global Ophthalmic Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Anti-allergy
1.2.3 Anti-VEGF Agents
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.3 Ophthalmic Drugs Segment by Application
1.3.1 Global Ophthalmic Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Ophthalmic Drugs Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Drugs Revenue 2019-2030
1.4.2 Global Ophthalmic Drugs Sales 2019-2030
1.4.3 Global Ophthalmic Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ophthalmic Drugs Market Competition by Manufacturers
2.1 Global Ophthalmic Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ophthalmic Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ophthalmic Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Ophthalmic Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Drugs, Product Type & Application
2.7 Ophthalmic Drugs Market Competitive Situation and Trends
2.7.1 Ophthalmic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Drugs Players Market Share by Revenue
2.7.3 Global Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Drugs Retrospective Market Scenario by Region
3.1 Global Ophthalmic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ophthalmic Drugs Global Ophthalmic Drugs Sales by Region: 2019-2030
3.2.1 Global Ophthalmic Drugs Sales by Region: 2019-2024
3.2.2 Global Ophthalmic Drugs Sales by Region: 2025-2030
3.3 Global Ophthalmic Drugs Global Ophthalmic Drugs Revenue by Region: 2019-2030
3.3.1 Global Ophthalmic Drugs Revenue by Region: 2019-2024
3.3.2 Global Ophthalmic Drugs Revenue by Region: 2025-2030
3.4 North America Ophthalmic Drugs Market Facts & Figures by Country
3.4.1 North America Ophthalmic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ophthalmic Drugs Sales by Country (2019-2030)
3.4.3 North America Ophthalmic Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ophthalmic Drugs Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ophthalmic Drugs Sales by Country (2019-2030)
3.5.3 Europe Ophthalmic Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ophthalmic Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Ophthalmic Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ophthalmic Drugs Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ophthalmic Drugs Sales by Country (2019-2030)
3.7.3 Latin America Ophthalmic Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ophthalmic Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ophthalmic Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Drugs Sales by Type (2019-2030)
4.1.1 Global Ophthalmic Drugs Sales by Type (2019-2024)
4.1.2 Global Ophthalmic Drugs Sales by Type (2025-2030)
4.1.3 Global Ophthalmic Drugs Sales Market Share by Type (2019-2030)
4.2 Global Ophthalmic Drugs Revenue by Type (2019-2030)
4.2.1 Global Ophthalmic Drugs Revenue by Type (2019-2024)
4.2.2 Global Ophthalmic Drugs Revenue by Type (2025-2030)
4.2.3 Global Ophthalmic Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Ophthalmic Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ophthalmic Drugs Sales by Application (2019-2030)
5.1.1 Global Ophthalmic Drugs Sales by Application (2019-2024)
5.1.2 Global Ophthalmic Drugs Sales by Application (2025-2030)
5.1.3 Global Ophthalmic Drugs Sales Market Share by Application (2019-2030)
5.2 Global Ophthalmic Drugs Revenue by Application (2019-2030)
5.2.1 Global Ophthalmic Drugs Revenue by Application (2019-2024)
5.2.2 Global Ophthalmic Drugs Revenue by Application (2025-2030)
5.2.3 Global Ophthalmic Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Ophthalmic Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Santen Pharmaceutical
6.1.1 Santen Pharmaceutical Corporation Information
6.1.2 Santen Pharmaceutical Description and Business Overview
6.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Santen Pharmaceutical Ophthalmic Drugs Product Portfolio
6.1.5 Santen Pharmaceutical Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Corporation Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bausch Health Ophthalmic Drugs Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Ophthalmic Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Ophthalmic Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Genentech
6.5.1 Genentech Corporation Information
6.5.2 Genentech Description and Business Overview
6.5.3 Genentech Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Genentech Ophthalmic Drugs Product Portfolio
6.5.5 Genentech Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Ophthalmic Drugs Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Industries Ophthalmic Drugs Product Portfolio
6.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.8 Actavis Generics
6.8.1 Actavis Generics Corporation Information
6.8.2 Actavis Generics Description and Business Overview
6.8.3 Actavis Generics Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Actavis Generics Ophthalmic Drugs Product Portfolio
6.8.5 Actavis Generics Recent Developments/Updates
6.9 Regeneron Pharmaceuticals
6.9.1 Regeneron Pharmaceuticals Corporation Information
6.9.2 Regeneron Pharmaceuticals Description and Business Overview
6.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Product Portfolio
6.9.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Ophthalmic Drugs Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Johnson and Johnson
6.11.1 Johnson and Johnson Corporation Information
6.11.2 Johnson and Johnson Ophthalmic Drugs Description and Business Overview
6.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson and Johnson Ophthalmic Drugs Product Portfolio
6.11.5 Johnson and Johnson Recent Developments/Updates
6.12 Bausch and Lomb
6.12.1 Bausch and Lomb Corporation Information
6.12.2 Bausch and Lomb Ophthalmic Drugs Description and Business Overview
6.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bausch and Lomb Ophthalmic Drugs Product Portfolio
6.12.5 Bausch and Lomb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Drugs Industry Chain Analysis
7.2 Ophthalmic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Drugs Production Mode & Process
7.4 Ophthalmic Drugs Sales and Marketing
7.4.1 Ophthalmic Drugs Sales Channels
7.4.2 Ophthalmic Drugs Distributors
7.5 Ophthalmic Drugs Customers
8 Ophthalmic Drugs Market Dynamics
8.1 Ophthalmic Drugs Industry Trends
8.2 Ophthalmic Drugs Market Drivers
8.3 Ophthalmic Drugs Market Challenges
8.4 Ophthalmic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
